Sumit chrono
7 months ago
Families in Cairo, Alexandria and across Egypt often hear about stem cells first. This page places cell therapy next to gene and drug research for Stargardt’s, so you can see where each stands.

Stargardt’s research follows three main paths. Gene approaches try to supply a working copy of the ABCA4 gene, drug approaches try to slow the build-up of toxic waste in the retina, and cell approaches aim to replace the failing support layer.
Each path suits a different stage of disease. Understanding which one applies to your child or to you prevents hope being placed in the wrong place.
A side-by-side view.
Described without exaggeration.
Human studies are small and short.
Most volunteers have already lost central vision.
Early work looks mainly at whether the procedure is tolerated.
Whether cells can protect or restore sight in the long term.
Practical next steps.
It decides which gene studies are relevant.
They show how much retina remains.
Not only cells.
The field moves quickly.
Eye Stem Cell Center brings together pioneers in stem cell biotechnology and highly experienced ophthalmologists to provide advanced regenerative eye care with compassion and precision.
Dr. Pallavi is renowned for her expertise in cataract and corneal surgeries. With thousands of successful procedures, she combines surgical precision with a patient‑first approach.
Get ConsultationDr. Robin specializes in advanced cataract surgery, refractive procedures, and keratoconus treatment. His clinical excellence ensures patients receive world‑class eye care.
Get ConsultationDr. Pawan is an expert in retinal disorders, diabetic retinopathy, and advanced retina procedures. His patient‑focused approach ensures precise treatment and long‑term vision care.
Get ConsultationNot as an approved treatment. Gene and drug studies are ongoing.
There is no proof that either is better, because they are tested at different stages.
Yes. Scans and reports can be sent for review before any other step.